Inhaltsverzeichnis
Anzeigen
At Long Last… Pay for Outcomes Starts to Replace Pay for Performance
Think of P4O as P4P with its eyes on the prize. Unfortunately, even ordinary P4P is not yet widespread.
Is the breast cancer drug Avastin the opening salvo that brings efficacy, toxicity, and costs together? Who will blink first — health plans, providers, regulators, or patients?
As the medical home concept grows, many in health care will have to define new roles
Health insurance plans need only bolster the following accepted guidelines to see a return on a very little bit of investment
With the advent of new disease-specific agents, some patients with HAE may find relief from its enormous physical and psychological toll
Departments
LEGISLATION & REGULATION
In the long run, health plans will benefit from the new rules. In the short run, hospitals say they already have enough economic pressures.
MEDICATION MANAGEMENT
Expect more denials as more specialty drugs are introduced and prescribed
COMPENSATION MONITOR
THE FORMULARY FILES
TOMORROW’S MEDICINE
For this condition that is largely confined to the Medicare population, a new treatment is now available
MANAGED CARE OUTLOOK
News & Commentary
Paul Lendner ist ein praktizierender Experte im Bereich Gesundheit, Medizin und Fitness. Er schreibt bereits seit über 5 Jahren für das Managed Care Mag. Mit seinen Artikeln, die einen einzigartigen Expertenstatus nachweisen, liefert er unseren Lesern nicht nur Mehrwert, sondern auch Hilfestellung bei ihren Problemen.